4//SEC Filing
Chan Phillip P. 4
Accession 0001104659-23-126421
CIK 0001175151other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:30 PM ET
Size
9.3 KB
Accession
0001104659-23-126421
Insider Transaction Report
Form 4
Chan Phillip P.
DirectorInterim CEO
Transactions
- Purchase
Common Stock
2023-12-13$1.33/sh+75,188$100,000→ 1,068,704 total - Purchase
Common Stock Warrant (Right to Buy)
2023-12-13+26,315→ 26,315 totalExercise: $2.00From: 2023-12-13Exp: 2028-12-13→ Common Stock (26,315 underlying)
Footnotes (5)
- [F1]These securities were purchased by the reporting person in the registered direct offering of CytoSorbents Corporation (the "Company"), which closed on December 13, 2023. In the offering, each share of common stock, par value $0.001 per share (the "Common Stock") of the Company was purchased together with an accompanying warrant to purchase up to 0.35 shares of Common Stock, at a combined offering price of $1.33 per share of Common Stock and accompanying warrant.
- [F2]Includes: (i) the following restricted stock units ("RSUs") (which vest as to two-thirds of the award on the first anniversary of the date of grant and onethird of the award on the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date) and will settle into shares of Common Stock upon vesting: 87,000 RSUs granted on July 7, 2023 and unvested as of the date hereof;
- [F3](continued from footnote 2) (ii) the following RSUs that will be settled into shares of Common Stock upon vesting upon a "Change In Control" of the Company as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 10,300 RSUs granted on March 15, 2018, (b) 18,700 RSUs granted on February 24, 2017, (c) 57,000 RSUs granted on June 7, 2016 and (d) 130,000 RSUs granted on April 8, 2015;
- [F4](continued from footnote 3) (iii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date) and will settle into shares of Common Stock upon vesting: 26,334 RSUs granted on August 10, 2022 and unvested as of the date hereof; and
- [F5](continued from footnote 4) (iv) 739,370 shares of Common Stock owned by the reporting person.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001442786
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:30 PM ET
- Size
- 9.3 KB